GlaxoSmithKline plc (GSK) Earns “Neutral” Rating from JPMorgan Chase & Co.
Several other analysts also recently weighed in on the company. Societe Generale restated a sell rating and set a GBX 1,320 ($17.23) target price on shares of GlaxoSmithKline plc in a research note on Wednesday, September 14th. BNP Paribas downgraded GlaxoSmithKline plc to an underperform rating and set a GBX 1,520 ($19.84) target price for the company. in a research note on Wednesday, September 14th. Liberum Capital restated a buy rating and set a GBX 1,900 ($24.80) target price on shares of GlaxoSmithKline plc in a research note on Tuesday, September 13th. Jefferies Group decreased their target price on GlaxoSmithKline plc from GBX 2,000 ($26.11) to GBX 1,900 ($24.80) and set a buy rating for the company in a research note on Tuesday, September 13th. Finally, HSBC restated a buy rating and set a GBX 1,970 ($25.71) target price on shares of GlaxoSmithKline plc in a research note on Monday, September 12th. Three investment analysts have rated the stock with a sell rating, sixteen have issued a hold rating and eight have given a buy rating to the stock. GlaxoSmithKline plc presently has an average rating of Hold and an average target price of GBX 1,676.44 ($21.88).
GlaxoSmithKline plc (LON:GSK) opened at 1645.00 on Friday. The company’s market capitalization is GBX 79.96 billion. The company’s 50-day moving average price is GBX 1,655.81 and its 200-day moving average price is GBX 1,530.22. GlaxoSmithKline plc has a 52 week low of GBX 1,227.50 and a 52 week high of GBX 1,716.50.
The business also recently declared a dividend, which will be paid on Thursday, October 13th. Investors of record on Thursday, August 11th will be paid a GBX 19 ($0.25) dividend. This represents a dividend yield of 1.12%. The ex-dividend date of this dividend is Thursday, August 11th.
In related news, insider Slaoui,Moncef purchased 28 shares of the business’s stock in a transaction that occurred on Friday, August 12th. The stock was acquired at an average cost of GBX 2,208 ($28.82) per share, for a total transaction of £618.24 ($807.00). Also, insider Cartwright,Stacey purchased 461 shares of the business’s stock in a transaction that occurred on Friday, July 1st. The stock was bought at an average price of GBX 1,559 ($20.35) per share, with a total value of £7,186.99 ($9,381.27).
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with Analyst Ratings Network's FREE daily email newsletter.